Boehringer lngelheim Therapeutics GmbH

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

Jurisdiction: DELegal Form: 2HBR

ACTIVE

LEI: 391200OM7ZQLVZV6LJ42

Summary

Boehringer lngelheim Therapeutics GmbH is an organization. It is a subsidiary of C.H. Boehringer Sohn AG & Co. KG.

Legal entity: GLEIF